ĐÁNH GIÁ TÁC NHÂN VI SINH VÀ TÌNH HÌNH ĐỀ KHÁNG KHÁNG SINH Ở BỆNH NHÂN ĐÁI THÁO ĐƯỜNG TÍP 2 CÓ VIÊM PHỔI BỆNH VIỆN TẠI BỆNH VIỆN ĐA KHOA THÀNH PHỐ CẦN THƠ NĂM 2022

Abstract

Background: Nosocomial pneumonia ranks second in hospital-acquired infections, increasing costs and burden of disease. Patients with type 2 diabetes are susceptible to many infections including pneumonia and are at high risk of developing nosocomial pneumonia. Objectives: 1) To survey on the rate of bacteria causing hospital-acquired pneumonia in patients with type 2 diabetes. 2) To survey on antibiotic resistance rates in some bacteria causing hospitalacquired pneumonia in patients with type 2 diabetes. Materials and method: The study was case series, retrospective and analytical. Sampling is based on hospital admission records from January 2020 to September 2022, the method sampling is convenience sampling. Results: Gram-negative bacteria accounted for the majority (97.4%). The three most common bacteria were Acinetobacter baumannii (36.8%), Klebsiella pneumoniae (36.8%), and Pseudomonas aeruginosa (13.2%). Except for Colistin (sensitive 100.0%), Gram-negative bacteria are highly resistant to Cephalosporin III and Fluroquinolone groups in most of the remaining antibiotics. Acinetobacter baumannii is almost completely resistant to antibiotics, except colistin (100.0% sensitive). Klebsiella pneumoniae and Pseudomonas aeruginosa were highly resistant to many antibiotics except colistin (sensitivity 100.0%). Conclusion: The three most common bacteria in diabetic patients with hospital-acquired pneumonia include Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa. The rate of Gram-negative bacteria resistant to antibiotics is very high but still sensitive to Colistin.